Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation
15 Février 2023 - 10:15PM
Conformis, Inc. (NASDAQ:CFMS) along with Bodycad Laboratories, Inc.
and Bodycad USA Corp. announced today that they have entered into a
settlement and license agreement that resolves the patent
infringement dispute filed by Conformis in June of 2021.
Conformis and Bodycad are pleased to have resolved
their ongoing patent litigation. The companies have amicably agreed
to an undisclosed amount for the dismissal of all patent litigation
between the companies along with a release and license to certain
Conformis patents related to patient-specific instrumentation and
knee implants.
About Conformis, Inc.
Founded in 2004, Conformis is a medical technology
company focused on advancing orthopedic patient care and creating a
world without joint pain. Its product portfolio is designed to
maximize surgeon and patient choice by offering fully personalized
solutions through its Image-to-Implant® Platinum Services℠ Program,
as well as data-informed, standardized solutions that combine many
benefits of personalization with the convenience and flexibility of
an off-the-shelf system. Conformis’ sterile, just-in-time,
Surgery-in-a-Box™ delivery system is available with all of its
implants and personalized, single-use instruments. Conformis owns
or exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints.
For more information, visit www.conformis.com. To
receive future releases in e-mail alerts, sign up at
ir.conformis.com.
CONTACT:Investor Contactir@conformis.com +1
(781) 374-5598
About Bodycad Laboratories,
Inc.
Bodycad is a Canadian company that is transforming the current
standards in orthopaedic implants to help surgeons and patients
achieve their mutual goal of a perfect Personalized
Restoration™. With the help of Bodycad’s proprietary software,
its integrated planning process as well as its fully vertically
integrated manufacturing facility, surgeons can quickly and
efficiently achieve specific design plans and personalized
restorations based on the precise anatomical specifications of
their patients. Bodycad’s unique approach offers patients and
surgeons the potential of greater comfort, fit and durability,
thereby making the pursuit of orthopaedic perfection possible.
Learn more at www.bodycad.com.
CONTACT:Corporate Headquarters+1 (866) 527-1388
Conformis (NASDAQ:CFMS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Conformis (NASDAQ:CFMS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024